Gene Therapy Policies Can Strike An Ethical Balance
On July 11, 2018, then-U.S. Food and Drug Administration Commissioner Scott Gottlieb made a public statement about the agency's efforts to advance the development of gene therapies.[1] Gottlieb pointed out that...To view the full article, register now.
Already a subscriber? Click here to view full article